⚡ News & Breakthroughs

A new FDA-cleared device reads the spinal cord's electrical response in real time and adjusts its own stimulation parameters automatically — ending the era of manual pain device tuning.

Synchron has closed a $95M Series D to advance its minimally invasive brain-computer interface — a stent-like device implanted through a blood vessel that requires no open-brain surgery.

The FDA has granted Breakthrough Device Designation to a closed-loop spinal cord stimulator that automatically adjusts stimulation in real time based on neural feedback.

Medtronic's BrainSense Adaptive DBS system — cleared by the FDA in 2025 — is the first brain implant that reads neural signals in real time and adjusts its own stimulation accordingly. The era of closed-loop brain medicine has begun.

A wearable bioelectric patch delivering calibrated electrical fields to damaged tissue achieved healing rates three times faster than standard care in a Phase II trial.